tirzepatide benefits other than weight loss Tirzepatide: A Breakthrough Approach to Losing Safely Retatrutide vs Tirzepatide: Which Weight-Loss

Funding The study and all support for the manuscript, including the journals Rapid Service Fee, were funded by Eli Lilly and Company, Indianapolis, USA

Based on the direct comparison described in the article, tirzepatide produced greater average weight loss than semaglutide in adults with obesity without diabetes

At refrigerated temperatures of 2 to 8 degrees Celsius (36 to 46 degrees Fahrenheit), stability extends to the full 28-day window

Patients using tirzepatide lost more weight compared to those in the placebo group

With the right approach, diet and medication can work together to support steady, sustainable weight loss

Keep detailed records during this transition